|
|
|
|
| LEADER |
01644nam a2200289 u 4500 |
| 001 |
EB000943559 |
| 003 |
EBX01000000000000000737149 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
150223 r ||| eng |
| 020 |
|
|
|a 0309260248
|
| 020 |
|
|
|a 9780309260244
|
| 100 |
1 |
|
|a Berger, Adam C.
|
| 245 |
0 |
0 |
|a Genome-based therapeutics
|h Elektronische Ressource
|b targeted drug discovery and development
|c Adam C. Berger and Steve Olson, rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy Institute of Medicine of the National Academies
|
| 260 |
|
|
|a Washington, D.C.
|b National Academies Press
|c 2012, c2012
|
| 300 |
|
|
|a 1 PDF file (xx, 89 p.)
|b ill
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Translational Medical Research
|
| 653 |
|
|
|a Drug Discovery
|
| 653 |
|
|
|a Genomics
|
| 700 |
1 |
|
|a Olson, Steve
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.)
|b Roundtable on Translating Genomic-Based Research for Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK100304
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The goal of the workshop will be to discuss how genomic and genetic data has been and will be used in the drug development process to improve aspects such as target identification, clinical trial design, pharmacogenomics approaches, biomarker development, and understanding disease biology. The workshop will also investigate the economic drivers, incentives, and models that use genomics in drug development
|